The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra-Reference-Cited by-同舟云学术

The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra

Published:1989-12 Issue:4 Volume:1 Page:279-295
ISSN:0936-3076
Container-title:Journal of Neural Transmission - Parkinson's Disease and Dementia Section
language:en
Short-container-title:J Neural Transm Gen Sect

Author:

Fornstedt B.,Brun A.,Rosengren E.,Carlsson A.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Neurology (clinical),General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/BF02263482.pdf

Reference34 articles.

1. Agrup G, Falck B, Jacobsson S, Rorsman H, Rosengren AM, Rosengren E (1974) 5-S-Cysteinyldopa in melanomas of caucasians. Acta Derm Venereol (Stockholm) 54: 21–23

2. Agrup G, Edholm L-E, Rorsman H, Rosengren E (1983) Diastereomers of 5-S-cysteinyl-DOPA. Acta Derm Venereol (Stockholm) 63: 59–61

3. Ambani LM, Melvin H, van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114–118

4. Anton AH, Sayre DF (1962) A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360–375

5. Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm 19 [Suppl]: 89–103

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology;NeuroToxicology;2024-07

2. Cerebrospinal fluid concentration gradients of catechols in synucleinopathies;Journal of Neurochemistry;2024-06-28

3. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects;Journal of Neural Transmission;2024-01-18

4. DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease;Progress in Neurobiology;2023-04

5. DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease and it exacerbates alpha-synuclein neurotoxicity;2022-07-03